Literature DB >> 21575626

Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation: a study to elucidate the action points of acidosis and search for putative target molecules.

Kohtaro Kato1, Ikuo Morita.   

Abstract

Acidosis promoted tartaric acid-resistant acid phosphatase-positive multinuclear cell (TRAP+MNC) or osteoclast formation. Large osteoclast or TRAP+LMNC formation was observed far more in an acidosis environment than in a physiologically neutral environment. One of the major action points of acidosis was determined to be located in the last phase of preosteoclast differentiation using a co-culture system and a soluble RANKL-dependent bone marrow cell culture system. On-going osteoclast formation in an acidosis environment markedly deteriorated when the medium was replaced with physiologically neutral medium within the first 6h; however, bone marrow cells previously stimulated in an acidosis environment for 9h differentiated into TRAP+LMNC in pH 7.4 medium. Messenger RNA (mRNA) expression levels of DC-STAMP, a key molecule in cell fusion, and NFATc1 did not increase in the acidosis environment compared with those under physiologically neutral conditions. Ruthenium red, a general TRP antagonist, deteriorated acidosis-promoted TRAP+LMNC formation. 4-Alpha-PDD, a TRPV4-specific agonist, added in the last 21 h of preosteoclast differentiation, potentiated TRAP+LMNC formation in a mild acidosis environment, showing synergism between TRPV4 activation and acidosis. RN1734, a TRPV4-specific antagonist, partly inhibited acidosis-promoted TRAP+LMNC formation. We thus narrowed down the major action points of acidosis in osteoclast formation and elucidated the characteristics of this system in detail. Our results show that acidosis effectively uses TRPV4 to drive large-scale cell fusion and also utilizes systems independently of TRPV4.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21575626     DOI: 10.1016/j.ejphar.2011.04.062

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Proton concentrations can be a major contributor to the modification of osteoclast and osteoblast differentiation, working independently of extracellular bicarbonate ions.

Authors:  Kohtaro Kato; Misao Matsushita
Journal:  J Bone Miner Metab       Date:  2013-07-16       Impact factor: 2.626

Review 2.  TRPV4 as a therapeutic target for joint diseases.

Authors:  Amy L McNulty; Holly A Leddy; Wolfgang Liedtke; Farshid Guilak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-18       Impact factor: 3.000

Review 3.  The Role of Ca2+-NFATc1 Signaling and Its Modulation on Osteoclastogenesis.

Authors:  Jung Yun Kang; Namju Kang; Yu-Mi Yang; Jeong Hee Hong; Dong Min Shin
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 4.  The Roles of Acidosis in Osteoclast Biology.

Authors:  Feng-Lai Yuan; Ming-Hui Xu; Xia Li; He Xinlong; Wei Fang; Jian Dong
Journal:  Front Physiol       Date:  2016-06-24       Impact factor: 4.566

5.  Gap junctional communication is involved in differentiation of osteoclasts from bone marrow and peripheral blood monocytes.

Authors:  Elina Kylmäoja; Miho Nakamura; Hanna Kokkonen-Puuperä; Veli-Pekka Ronkainen; Petri Lehenkari; Juha Tuukkanen
Journal:  Heliyon       Date:  2018-05-07

6.  TRPV4 Inhibition Improved Myelination and Reduced Glia Reactivity and Inflammation in a Cuprizone-Induced Mouse Model of Demyelination.

Authors:  Meiying Liu; Xuan Liu; Lei Wang; Yu Wang; Fuxing Dong; Jian Wu; Xuebin Qu; Yanan Liu; Zhian Liu; Hongbin Fan; Ruiqin Yao
Journal:  Front Cell Neurosci       Date:  2018-11-05       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.